According to Taysha Gene Therapies's latest financial reports the company's current revenue (TTM) is S$16.76 M. In 2023 the company made a revenue of S$20.4 M an increase over the revenue in the year 2022 that were of S$3.35 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.